Recent News
Milestones
- The Mombasa Research Program celebrates 25 powerful years of HIV research
- Overbaugh Lab Celebrates 30 years:
Julie and Dara in the News
- Dr. Julie Overbaugh elected to National Academy of Sciences (courtesy of Center News)
- HIV research is speeding COVID-19 response: Dr. Julie Overbaugh (video)
- Scientists have never been more important: Dr. Julie Overbaugh (video)
- Dr. Julie Overbaugh elected to American Academy of Arts & Sciences
- HIV researcher Dr. Julie Overbaugh gives Bernard Fields Lecture at CROI
- Drs. Harmit Malik and Dara Lehman win mentorship awards (courtesy of Center News)
- HIV researcher Julie Overbaugh leads Hutch graduate education
- Fred Hutch researcher Dr. Julie Overbaugh receives prestigious Nature award for mentoring in science
Member Awards
Our Science in the News
- Bottleneck Breakthrough: Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry
- Vaccine targets that accommodate evolving SARS-CoV-2 variants
- Using mathematical models to tell time of initial HIV infection in infants
- Differential immune responses between mothers and their infants to SARS-CoV-2
- Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
- The impact of antibodies to other coronaviruses on risk of SARS-CoV-2 infection in mothers and infants
- A bit of hit and miss – how well antibody responses in pre-clinical models resemble human responses
- A new path forward: A potential route to effective HIV vaccines
- ADCC-mediating antibodies correlate with HIV-positive infant survival
- New insights into the breast milk virome in women with HIV
- How do antibodies evolve to kill HIV-infected cells?
- TOP delivery of CRISPR-Cas9 machinery to primary T cells
- Phage display libraries and deep mutational scanning to map antibody epitopes in HIV-1
- Herpesvirus infections may affect the size of the HIV reservoir in ART-treated children
- Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
- How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
- Too much of a good thing? IFITM3 only restricts Zika virus when overexpressed
- Cracking the code of HIV-1 entry into macaque cells
- Defining the role of maternal neutralizing antibodies in mother-to-child HIV transmission
- Superinfection provides insights into HIV-1 reservoir dynamics
- A new step forward in understanding mother-to-child transfer of HIV-1
- Working towards better HIV-1 preclinical models
- Time for HIV to show its hand
- Cutting-edge approach maps HIV's escape routes
- Superinfection to the rescue
- HIV DNA reservoir following treatment interruption in Kenyan infants
- Comparing human and monkey proteins reveals determinants of HIV-1 host cell entry
- Insights from infants could inform HIV vaccine design
- HIV superinfection may inform vaccine design
- New library of HIV mutants could inform vaccine design
Other
Fred Hutchinson Cancer Center | 1100 Fairview Ave. N., Seattle, WA 98109
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.